查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1722482

肝病治療市場報告（按治療類型、疾病類型（肝炎、自體免疫疾病、非酒精性脂肪肝、癌症、遺傳性疾病等）、最終用戶和地區分類）2025 年至 2033 年

Liver Disease Treatment Market Report by Treatment Type, Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease, Cancer, Genetic Disorders, and Others), End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2024年全球肝病治療市場規模達251億美元。展望未來， IMARC Group預計到2033年市場規模將達到404億美元，2025-2033年期間的成長率（CAGR）為5.44%。全球老年人口不斷成長，容易患上肝病等多種慢性疾病，刺激了市場的發展。

肝臟是人體的重要器官，具有儲存維生素和營養物質、清除血液中的有害物質、維持體內化學物質的適當平衡等重要功能。癌症、肝炎、自體免疫疾病和遺傳性疾病是一些常見的肝臟疾病。這些疾病通常由感染、遺傳、肥胖、糖尿病和免疫系統異常引起。一些廣泛使用的肝病治療技術包括疫苗、化療、抗病毒藥物、免疫球蛋白、皮質類固醇和免疫抑制劑。肝病治療有助於膽固醇和荷爾蒙的排泄，增加膽汁的產生和酵素的活化。

肝病治療市場趨勢：

全球老年人口的不斷成長，導致老年人易患各種慢性疾病，包括肝病，這是推動市場成長的主要因素之一。不斷變化的飲食模式和久坐的生活方式正在推動市場成長。此外，由於高膽固醇、肥胖、高血壓和糖尿病導致的脂肪肝盛行率不斷上升，也有利於市場的成長。此外，生物人工肝的發展等各種技術進步正在為市場成長提供動力。它利用再生肝細胞來取代肝臟功能，廣泛用於治療急性肝衰竭患者。與此一致，抗病毒藥物因其安全有效、有助於抑制乙肝病毒、並有助於降低肝硬化和肝細胞癌的風險而迅速被採用，對市場成長產生了積極影響。除此之外，研發活動的增加、醫療保健產業的顯著成長以及政府為促進公共健康而實施的各種措施都為市場創造了積極的前景。

本報告回答的關鍵問題

  • 2024年全球肝病治療市場規模？ 2025-2033年全球肝病治療市場的預期成長率是多少？
  • 推動全球肝病治療市場的關鍵因素有哪些？
  • COVID-19 對全球肝病治療市場有何影響？
  • 根據治療類型，全球肝病治療市場如何分佈？
  • 根據疾病類型，全球肝病治療市場是如何分佈的？
  • 根據最終用戶，全球肝病治療市場是如何分佈的？
  • 全球肝病治療市場的主要區域有哪些？
  • 全球肝病治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球肝病治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依治療類型

  • 抗病毒藥物
  • 免疫抑制劑
  • 疫苗
  • 免疫球蛋白
  • 皮質類固醇
  • 標靶治療
  • 化療

第7章：市場區隔：依疾病類型

  • 肝炎
  • 自體免疫疾病
  • 非酒精性脂肪肝（NAFLD）
  • 癌症
  • 遺傳性疾病
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • AbbVie Inc.
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Emergent BioSolutions Inc.
    • F. Hoffmann-La Roche AG
    • Gilead Sciences Inc.
    • GlaxoSmithKline plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Viatris Inc.
Product Code: SR112025A5023

The global liver disease treatment market size reached USD 25.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 40.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.44% during 2025-2033. The growing elderly population worldwide, which is prone to several chronic illnesses, including liver disease, is stimulating the market.

The liver is a vital organ of the human body that performs significant functions, such as storing vitamins and nutrients, removing harmful substances from the blood, and maintaining an adequate balance of chemicals in the body. Cancer, hepatitis, autoimmune diseases, and genetic disorders are some common liver diseases. These diseases are commonly caused by infections, genetics, obesity, diabetes, and immune system abnormalities. Some of the widely used therapeutic techniques for liver diseases include vaccines, chemotherapy, antiviral drugs, immunoglobulins, corticosteroids, and immunosuppressants. Liver disease treatment aids in the excretion of cholesterol and hormones, increases bile production and enzyme activation.

Liver Disease Treatment Market Trends:

The rising geriatric population, which is suspetible to various chronic ailments, including liver disease, across the globe is one of the prime factors driving the growth of the market. The changing dietary patterns and sedentary lifestyles are boosting the market growth. Additionally, the increasing prevalence of fatty liver disease due to high cholesterol, obesity, hypertension (high blood pressure), and diabetes is favoring the market growth. Moreover, various technological advancements, such as the development of the bioartificial liver, are providing an impetus to the market growth. It utilizes regenerated liver cells to replace liver functions and is widely used for acute liver failure patients. In line with this, the rapid adoption of antiviral drugs as they are safe and effective, assist in suppressing the hepatitis B virus, and help in reducing the risk of developing cirrhosis and hepatocellular carcinoma, is positively impacting the market growth. Apart from this, increasing research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote public health are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Treatment Type:

  • Antiviral Drugs
  • Immunosuppressants
  • Vaccines
  • Immunoglobulins
  • Corticosteroids
  • Targeted Therapy
  • Chemotherapy

Breakup by Disease Type:

  • Hepatitis
  • Autoimmune Diseases
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Cancer
  • Genetic Disorders
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global liver disease treatment market in 2024?
  • 2.What is the expected growth rate of the global liver disease treatment market during 2025-2033?
  • 3.What are the key factors driving the global liver disease treatment market?
  • 4.What has been the impact of COVID-19 on the global liver disease treatment market?
  • 5.What is the breakup of the global liver disease treatment market based on the treatment type?
  • 6.What is the breakup of the global liver disease treatment market based on the disease type?
  • 7.What is the breakup of the global liver disease treatment market based on the end user?
  • 8.What are the key regions in the global liver disease treatment market?
  • 9.Who are the key players/companies in the global liver disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Liver Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Antiviral Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vaccines
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulins
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Corticosteroids
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Targeted Therapy
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Chemotherapy
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Disease Type

  • 7.1 Hepatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Autoimmune Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Non-alcoholic Fatty Liver Disease (NAFLD)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Genetic Disorders
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Astellas Pharma Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Emergent BioSolutions Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Gilead Sciences Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 GlaxoSmithKline plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Merck & Co. Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Novartis AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Pfizer Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Sanofi S.A.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14 Takeda Pharmaceutical Company Limited
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis
    • 14.3.15 Viatris Inc.
      • 14.3.15.1 Company Overview
      • 14.3.15.2 Product Portfolio
      • 14.3.15.3 Financials

List of Figures

  • Figure 1: Global: Liver Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Liver Disease Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Liver Disease Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Liver Disease Treatment Market: Breakup by Treatment Type (in %), 2024
  • Figure 5: Global: Liver Disease Treatment Market: Breakup by Disease Type (in %), 2024
  • Figure 6: Global: Liver Disease Treatment Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Liver Disease Treatment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Liver Disease Treatment (Antiviral Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Liver Disease Treatment (Antiviral Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Liver Disease Treatment (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Liver Disease Treatment (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Liver Disease Treatment (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Liver Disease Treatment (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Liver Disease Treatment (Immunoglobulins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Liver Disease Treatment (Immunoglobulins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Liver Disease Treatment (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Liver Disease Treatment (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Liver Disease Treatment (Targeted Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Liver Disease Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Liver Disease Treatment (Chemotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Liver Disease Treatment (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Liver Disease Treatment (Hepatitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Liver Disease Treatment (Hepatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Liver Disease Treatment (Autoimmune Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Liver Disease Treatment (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Liver Disease Treatment (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Liver Disease Treatment (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Liver Disease Treatment (Genetic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Liver Disease Treatment (Genetic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Liver Disease Treatment (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Liver Disease Treatment (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Liver Disease Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Liver Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Liver Disease Treatment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Liver Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Liver Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Liver Disease Treatment Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Liver Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Liver Disease Treatment Industry: SWOT Analysis
  • Figure 90: Global: Liver Disease Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Liver Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Liver Disease Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Liver Disease Treatment Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 3: Global: Liver Disease Treatment Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 4: Global: Liver Disease Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Liver Disease Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Liver Disease Treatment Market: Competitive Structure
  • Table 7: Global: Liver Disease Treatment Market: Key Players